Trial Profile
Efficacy of Tenofovir and Enticavir for Recurrent Hepatitis after Cessation of Long-term Nucleoside Analogue Therapy in Chronic Hepatitis B Patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 29 Mar 2018 New trial record